freenome

2023年2月22日 — Biotech firm Freenome creates diagnostic tests to detect life-threatening diseases like cancer in the earliest stages with Google Cloud.

2021年12月8日 — Freenome 平台使用機器學習人工智慧來分析常規抽血中的基因體、轉錄體、甲基體和蛋白質體學數據，以發現癌症的最早跡象，包括來自腫瘤和非腫瘤來源的生物 ...

2022年1月12日 — 多體學(multiomics)血液檢測開發公司Freenome， 於去年底完成D輪3億美元募資，美國時間11日，Freenome再宣布，獲得製藥、診斷巨頭羅氏(Roche)2.9億 ...

2022年2月11日 — Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their ...

Freenome的內部職缺 · Senior Network Engineer (Contractor) · Senior Director, Market Access Strategy · Supply Chain Business Manager.

Freenome aims to detect cancer earlier and make cancer screening more accessible through standard blood tests. early cancer detection blood ...

We are committed to quality. At Freenome, our mission is to empower everyone to prevent, detect, and treat disease by developing high-quality diagnostic tests.

At Freenome, we're developing next-generation blood tests for early cancer detection, powered by our multiomics platform.

How Freenome's multiomics platform looks beyond tumor signals. Multiomics is the comprehensive analysis of blood by looking across multiple levels of biology, ...

Manuscripts · Multicancer Screening: One Size Does Not Fit All · Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing ...